Literature DB >> 19567881

Generation and phenotypic analysis of protein S-deficient mice.

François Saller1, Anne C Brisset, Svetlana N Tchaikovski, Monica Azevedo, Roman Chrast, José A Fernández, Marc Schapira, Tilman M Hackeng, John H Griffin, Anne Angelillo-Scherrer.   

Abstract

Protein S (PS) is an important natural anticoagulant with potentially multiple biologic functions. To investigate further the role of PS in vivo, we generated Pros(+/-) heterozygous mice. In the null (-) allele, the Pros exons 3 to 7 have been excised through conditional gene targeting. Pros(+/-) mice did not present any signs of spontaneous thrombosis and had reduced PS plasma levels and activated protein C cofactor activity in plasma coagulation and thrombin generation assays. Tissue factor pathway inhibitor cofactor activity of PS could not be demonstrated. Heterozygous Pros(+/-) mice exhibited a notable thrombotic phenotype in vivo when challenged in a tissue factor-induced thromboembolism model. No viable Pros(-/-) mice were obtained through mating of Pros(+/-) parents. Most E17.5 Pros(-/-) embryos were found dead with severe intracranial hemorrhages and most likely presented consumptive coagulopathy, as demonstrated by intravascular and interstitial fibrin deposition and an increased number of megakaryocytes in the liver, suggesting peripheral thrombocytopenia. A few E17.5 Pros(-/-) embryos had less severe phenotype, indicating that life-threatening manifestations might occur between E17.5 and the full term. Thus, similar to human phenotypes, mild heterozygous PS deficiency in mice was associated with a thrombotic phenotype, whereas total homozygous deficiency in PS was incompatible with life.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19567881      PMCID: PMC2745849          DOI: 10.1182/blood-2009-03-209031

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

1.  Homozygous protein S deficiency: 7-year follow-up.

Authors:  C Mahasandana; G Veerakul; V S Tanphaichitr; V Suvatte; N Opartkiattikul; W E Hathaway
Journal:  Thromb Haemost       Date:  1996-12       Impact factor: 5.249

2.  Mice with a severe deficiency in protein C display prothrombotic and proinflammatory phenotypes and compromised maternal reproductive capabilities.

Authors:  Angelina J Lay; Zhong Liang; Elliot D Rosen; Francis J Castellino
Journal:  J Clin Invest       Date:  2005-05-05       Impact factor: 14.808

3.  Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.

Authors:  Z F Huang; D Higuchi; N Lasky; G J Broze
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

4.  Homozygous protein S deficiency due to a one base pair deletion that leads to a stop codon in exon III of the protein S gene.

Authors:  E Gómez; M R Ledford; C H Pegelow; P H Reitsma; R M Bertina
Journal:  Thromb Haemost       Date:  1994-06       Impact factor: 5.249

5.  Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.

Authors:  L R Jalbert; E D Rosen; L Moons; J C Chan; P Carmeliet; D Collen; F J Castellino
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

6.  The absence of the blood clotting regulator thrombomodulin causes embryonic lethality in mice before development of a functional cardiovascular system.

Authors:  R D Rosenberg
Journal:  Thromb Haemost       Date:  1995-07       Impact factor: 5.249

7.  Protein S binds to and inhibits factor Xa.

Authors:  M J Heeb; J Rosing; H M Bakker; J A Fernandez; G Tans; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

8.  Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C.

Authors:  M J Heeb; R M Mesters; G Tans; J Rosing; J H Griffin
Journal:  J Biol Chem       Date:  1993-02-05       Impact factor: 5.157

9.  Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C.

Authors:  J Rosing; L Hoekema; G A Nicolaes; M C Thomassen; H C Hemker; K Varadi; H P Schwarz; G Tans
Journal:  J Biol Chem       Date:  1995-11-17       Impact factor: 5.157

10.  The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases.

Authors:  T N Stitt; G Conn; M Gore; C Lai; J Bruno; C Radziejewski; K Mattsson; J Fisher; D R Gies; P F Jones
Journal:  Cell       Date:  1995-02-24       Impact factor: 41.582

View more
  35 in total

Review 1.  TAM receptor signaling and autoimmune disease.

Authors:  Carla V Rothlin; Greg Lemke
Journal:  Curr Opin Immunol       Date:  2010-10-26       Impact factor: 7.486

2.  Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor.

Authors:  Donghui Zhu; Yaoming Wang; Itender Singh; Robert D Bell; Rashid Deane; Zhihui Zhong; Abhay Sagare; Ethan A Winkler; Berislav V Zlokovic
Journal:  Blood       Date:  2010-03-26       Impact factor: 22.113

Review 3.  TAM receptor signaling in immune homeostasis.

Authors:  Carla V Rothlin; Eugenio A Carrera-Silva; Lidia Bosurgi; Sourav Ghosh
Journal:  Annu Rev Immunol       Date:  2015-01-14       Impact factor: 28.527

4.  Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.

Authors:  Fabian Stavenuiter; Nicole F Davis; Erning Duan; Andrew J Gale; Mary J Heeb
Journal:  Thromb Haemost       Date:  2012-12-13       Impact factor: 5.249

5.  Phosphorylation of protein S by platelet kinases enhances its activated protein C cofactor activity.

Authors:  Fabian Stavenuiter; Andrew J Gale; Mary J Heeb
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

6.  Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.

Authors:  T J Girard; K Grunz; N M Lasky; J P Malone; G J Broze
Journal:  J Thromb Haemost       Date:  2018-10-22       Impact factor: 5.824

Review 7.  Tyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancer.

Authors:  Carla V Rothlin; Jonathan A Leighton; Sourav Ghosh
Journal:  Inflamm Bowel Dis       Date:  2014-08       Impact factor: 5.325

Review 8.  The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

Authors:  Silvio Danese; Stefania Vetrano; Li Zhang; Victoria A Poplis; Francis J Castellino
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

9.  Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.

Authors:  T J Girard; N M Lasky; K Grunz; G J Broze
Journal:  J Thromb Haemost       Date:  2018-12-16       Impact factor: 5.824

10.  Exacerbated venous thromboembolism in mice carrying a protein S K196E mutation.

Authors:  Fumiaki Banno; Toshiyuki Kita; José A Fernández; Hiroji Yanamoto; Yuko Tashima; Koichi Kokame; John H Griffin; Toshiyuki Miyata
Journal:  Blood       Date:  2015-08-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.